12/3 Business Wire Health: Alternative Medicine News

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Business Wire Health: Alternative Medicine News Regenocyte Therapeutic Announces Successful Treatment of Cardiomyopathy for Retired Teacher Using Adult Stem Cells December 2, 2009 at 4:13 pm NAPLES, Fla.--(BUSINESS WIRE)--Regenocyte Therapeutic has announced results for the successful treatment of cardiomyopathy for retired high school teacher, Leonard Narracci. In this ground-breaking treatment, he was injected with his own stem cells by Regenocyte Therapeutic, headquartered in Bonita Springs, Florida, and has experienced remarkable improvement in his condition. Cardiomyopathy is a heart condition that affects, among other things, the amount of blood that gets pumped out of the hea Media Files ViewMedia?mgid=160400&vid=2 (2 KB) Absorption Systems Launches New Drug Metabolism Assays December 2, 2009 at 9:00 am EXTON, Pa.--(BUSINESS WIRE)--Absorption Systems, a leader in drug safety and ADMET (absorption, distribution, metabolism, excretion and toxicity) testing, today announced the introduction of a more complete series of drug metabolism assays designed to support the pharmaceutical R&D process, from early-stage discovery through late-stage clinical development. The tests are intended to provide researchers with a more comprehensive picture of the role that metabolites, which are generally associ Media Files ViewMedia?mgid=206765&vid=2 (2 KB) Cannabis Science Inc. Reports on Litigation Settlement and Debt Elimination A Vote of Confidence in Dr. Melamede, and "The Huge Potential of Our Company" December 2, 2009 at 8:39 am COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science Inc. (NASD OTCBB: CBIS), an emerging pharmaceutical cannabis company, reported today that it has settled pending litigation with K & D Equity Investments, Inc. and South Beach Live, Inc., and reached agreements with its largest creditors to convert their debt for shares. Richard Cowan, CFO, stated, “Settlement of the K & D and South Beach lawsuits frees up our management team to focus on testing and launching our new OTC pr   This email was sent to billionlys.asdf1234@blogger.com.  Manage Your Account Don't want to receive this feed any longer? Unsubscribe here.